4178.TW · STEMCYTE
Taiwan · RS rating 43 · As of 2026-10-08
| Price | 19.60 TWD |
|---|---|
| 1-day change | +8.6% |
| RS rating (overall / 1M / 3M / 12M) | 43 / 88 / 71 / 22 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 21 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -31.6% |
| Sales growth Q/Q | +10.1% |
| Distance from 52-week high | +41.0% |
| Market cap (USD) | $121.0M |